Laughrea, P.-A., and M. Hébert. “Staying Ahead of Dupilumab-Associated Ocular Surface Disease”. Canadian Eye Care Today, vol. 1, no. 2, Sept. 2022, pp. 8–13, doi:10.58931/cect.2022.1212.